Updated systematic literature review and network meta-analysis of cladribine tablets versus currently approved disease-modifying treatments for active relapsing-remitting multiple sclerosis.
Harty GT, Jones M, Maheshwari V, Saipriya J
Mult Scler Relat Disord. 2026 May 02; 111:107214. PMID: 42134165.Abstract
